Literature DB >> 27932238

Gender differences in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: Clinical manifestations, electrophysiological properties, substrate characteristics, and prognosis of radiofrequency catheter ablation.

Chin-Yu Lin1, Fa-Po Chung2, Yenn-Jiang Lin3, Shih-Lin Chang2, Li-Wei Lo2, Yu-Feng Hu2, Ta-Chuan Tuan2, Tze-Fan Chao2, Jo-Nan Liao2, Yao-Ting Chang2, Yun-Yu Chen4, Rohit Walia5, Abigail Louise D Te5, Shinya Yamada5, Shih-Ann Chen2.   

Abstract

BACKGROUND: Gender differences in the penetrance and clinical expression of genetic mutations have been reported in patients with arrhythmogenic right ventricular (RV) dysplasia/cardiomyopathy (ARVD/C). Our study aimed at clarifying the impact of gender on ventricular substrates and clinical outcomes after radiofrequency catheter ablation (RFCA).
METHODS: Patients with ARVD/C underwent RFCA for drug-refractory ventricular arrhythmias (VAs) were consecutively enrolled. Baseline characteristics, electrocardiograms, ventricular substrates, and VA recurrences after RFCA were extracted for comparison between genders.
RESULTS: A total of 70 consecutive unselected patients with definite ARVD/C (36 men [51%], age 45±14years) were studied. Male patients had a higher incidence of sustained ventricular tachycardia and ventricular fibrillation or sudden cardiac arrest as initial manifestations. Electroanatomical mapping demonstrated that men with ARVD/C had a larger epicardial RV unipolar low-voltage zone, a larger endocardial and epicardial area with late potentials, and longer local abnormal ventricular activity. Cox regression analysis demonstrated that gender and late potential area predicted the recurrences of VAs.
CONCLUSION: Patients with ARVD/C displayed different characteristics of VAs and substrate properties between men and women. Male gender and the presence of larger area of abnormal electrograms independently predicted VA recurrences after RFCA.
Copyright © 2016 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Arrhythmogenic right ventricular dysplasia/cardiomyopathy; Gender differences; Late potential; Substrate characteristics; Ventricular arrhythmias

Mesh:

Year:  2016        PMID: 27932238     DOI: 10.1016/j.ijcard.2016.11.055

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Impact of sex on clinical, procedural characteristics and outcomes of catheter ablation for ventricular arrhythmias according to underlying heart disease.

Authors:  Timmy Pham; Richard Bennett; Juliana Kanawati; Timothy Campbell; Samual Turnbull; Stuart P Thomas; Saurabh Kumar
Journal:  J Interv Card Electrophysiol       Date:  2022-03-30       Impact factor: 1.900

Review 2.  Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

Authors:  Fa Po Chung; Chin Yu Lin; Yenn Jiang Lin; Shih Lin Chang; Li Wei Lo; Yu Feng Hu; Ta Chuan Tuan; Tze Fan Chao; Jo Nan Liao; Ting Yung Chang; Shih Ann Chen
Journal:  Korean Circ J       Date:  2018-10       Impact factor: 3.243

Review 3.  Predictors of cardiac arrhythmic events in non coronary artery disease patients.

Authors:  C Balla; F Vitali; A Brieda; F Gualandi; A Ferlini; M Bertini; R Ferrari
Journal:  BMC Cardiovasc Disord       Date:  2019-05-02       Impact factor: 2.298

Review 4.  Sex-specific influence on cardiac structural remodeling and therapy in cardiovascular disease.

Authors:  Elise L Kessler; Mathilde R Rivaud; Marc A Vos; Toon A B van Veen
Journal:  Biol Sex Differ       Date:  2019-02-04       Impact factor: 5.027

Review 5.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) in clinical practice.

Authors:  Ka Hou Christien Li; George Bazoukis; Tong Liu; Guangping Li; William K K Wu; Sunny Hei Wong; Wing Tak Wong; Yat Sun Chan; Martin C S Wong; Katharina Wassilew; Vassilios S Vassiliou; Gary Tse
Journal:  J Arrhythm       Date:  2017-12-21

6.  Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy.

Authors:  Chris Miles; Gherardo Finocchiaro; Michael Papadakis; Belinda Gray; Joseph Westaby; Bode Ensam; Joyee Basu; Gemma Parry-Williams; Efstathios Papatheodorou; Casey Paterson; Aneil Malhotra; Jan Lukas Robertus; James S Ware; Stuart A Cook; Angeliki Asimaki; Adam Witney; Irina Chis Ster; Maite Tome; Sanjay Sharma; Elijah R Behr; Mary N Sheppard
Journal:  Circulation       Date:  2019-04-09       Impact factor: 29.690

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.